CDK12 and neoplasm: In this study, we have revealed the metabolic landscape of CRPC with CDK12 deficiency and shown that CDK12 deficiency enhances the energy metabolism of CRPC cells, including improving the TCA cycle and ETC activity, to sustain the growth and survival of tumour cells.